| Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis R Lei, J Tang, X Zhuang, R Deng, G Li, J Yu, Y Liang, J Xiao, HY Wang, ... Oncogene 33 (10), 1287-1296, 2014 | 153 | 2014 |
| MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells J Yu, R Lei, X Zhuang, X Li, G Li, S Lev, MF Segura, X Zhang, G Hu Nature communications 7 (1), 1-12, 2016 | 122 | 2016 |
| A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity J Hu, G Li, P Zhang, X Zhuang, G Hu Cell death & disease 8 (3), e2679-e2679, 2017 | 111 | 2017 |
| DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis Y Wang, R Lei, X Zhuang, N Zhang, H Pan, G Li, J Hu, X Pan, Q Tao, D Fu, ... The Journal of clinical investigation 124 (4), 1646-1659, 2014 | 90 | 2014 |
| Nanoplatforms for mRNA therapeutics CM Z Chen, G Li, T Welte, H Shen Advanced Therapeutics 2000099, 2020 | 89* | 2020 |
| The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis G Li, M Li, J Hu, R Lei, H Xiong, H Ji, H Yin, Q Wei, G Hu Oncogene 36 (7), 989-998, 2017 | 82 | 2017 |
| Biomarker studies in early detection and prognosis of breast cancer G Li, J Hu, G Hu Translational Research in Breast Cancer, 27-39, 2017 | 75 | 2017 |
